BXP BXP
Real Estate · REIT - Office · Synthos Deep Dive · 2026-07-03
The Overview
BXP is a landlord. It builds and rents out top-tier office towers in five expensive cities — Boston, New York, San Francisco, Washington DC, and Los Angeles. It is set up as a REIT, which means it must pay out most of its profit to shareholders as a dividend; right now that dividend is about 4% a year, and the company earns enough to cover it.
Is the stock cheap or expensive? On the measure that matters for a landlord — cash rental profit per share (called "FFO") — it looks cheap: you pay under $10 for every $1 of yearly cash profit. But cheap is not the same as good. The rent it collects has basically stopped growing, and the company owes a lot of money — about eight years' worth of profit in debt — which is dangerous when interest rates stay high and offices sit half-empty in some cities.
Our verdict is Watch: not a buy, not a sell. It could be fine as a small income holding if you specifically want office-property exposure and the 4% dividend, but it is not a wealth-builder.
Here's what our three scores mean in everyday terms:
- Downside Risk 7/10 (elevated). The heavy debt load and the fact that the stock already fell nearly in half from its peak make this riskier than average.
- Growth Quality 3/10 (weak). The business barely grows and doesn't earn high returns — it's a steady rent-collector, not a rising star.
- Exponential Potential 2/10 (very low). This is a mature, one-product landlord. Do not expect it to multiply your money.
The one big worry: the world may permanently need less office space (remote/hybrid work), and BXP's large debt magnifies any pain if rents or property values fall.
Putting a number on it: our fair-value estimate is $70 against a current price of $69.32 — real upside if our numbers are right.
Our summary metrics
8.2× net-debt/EBITDA and a −48% peak drawdown dominate; cheap on FFO but leverage & office cyclicality are the risk.
~1% revenue growth, flat-to-down FFO, thin 6% ROE — an income REIT, not a grower.
Mature, decelerating, single-asset-class office REIT; no room-to-run optionality — the opposite of exponential.
What does “fair value” mean?
Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.
The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Exponential Potential
Mature, decelerating, single-asset-class office REIT; no room-to-run optionality — the opposite of exponential.
What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.
Deeper analysis
Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.
Reference table
| Street consensus | $65.50 (high $72 / low $61; 24 Buy · 17 Hold · 1 Sell) — context, not our anchor |
| Valuation | ~9.9× FY26E FFO ($6.97 mid) · P/E 35× trailing (misleading for a REIT) · EV/EBITDA 14× · net-debt/EBITDA 8.2× |
| Dividend | $2.80/yr, ~4.0% yield, ~40% of FFO — covered and a core part of the return |
| Technicals | Recovering — $69.32, above 50/200-DMA, RSI 62; but only +1.8% 12-mo (SPY +21%) and −48% max drawdown from peak |
| Conviction | Low — 0 expert voices in the KB; the call rests entirely on fundamentals + quant |
| Position sizing | Income/tactical only, ≤2% if held for the yield — not a core holding |
What the experts actually said
No independent expert claims in the Synthos knowledge base yet for BXP — this dive is fundamentals- and technicals-driven, not panel-driven.
Price & moving averages 12 months · 50 & 200-day averages · 52-week range
Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.
Data summary: last close $69.32, 1% above the 50-day average ($68), 9% above the 200-day average ($64) — an uptrend. 12% below the 52-week high of $79, 36% above the 52-week low of $51.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Data summary: price $69.32 is currently inside the band (band $66–$72).
RSI (14) momentum gauge · 0–100
Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 52.
MACD 12 / 26 / 9 · trend & momentum
The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.
Data summary: MACD is currently above its signal line by 0.13, positive momentum.
Relative performance vs S&P 500 & its sector (XLRE (sector)), set to 100 a year ago
Solid = BXP · dashed = S&P 500 · dotted = XLRE (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
1. What it is
BXP, Inc. (NYSE: BXP), formerly Boston Properties, is the largest publicly traded owner/developer of premier Class-A office ("premier workplace") properties in the US, structured as a REIT. As of Q1'26 the portfolio totals ~50.4M square feet across 164 properties (including six under construction/redevelopment), concentrated in six gateway markets: Boston, Los Angeles, New York, San Francisco, Seattle, and Washington DC. It is externally the definition of a single-asset-class, gateway-city office landlord. Fiscal year ends December 31; CEO is Owen Thomas.
Revenue mix (FY2025, from FMP segmentation + filings):
- By geography (rental revenue): Boston $1.29B (~37%) · New York $1.05B (~30%) · San Francisco $524M (~15%) · Washington DC $445M (~13%) · Los Angeles $71M · Seattle $49M. The base is heavily Boston + New York; San Francisco (~15%) is the most secularly challenged office market and the key swing exposure.
- By service line (non-rental): Parking & other $143M · Hotel $50M · Management services $37M · Other real estate $16M — small relative to the ~$3.15B lease-revenue core.
The core economic engine is rent from long-term leases on trophy office assets. The strategic story management is telling (Investor Day, Sept 2025) is defensive: lease up the ~350-bps gap between leased and occupied space (~1.6M sq ft of signed-but-not-commenced leases), sell non-strategic assets (~$1.2B of proceeds to date) to de-lever, and let the flight-to-quality within office favor the best buildings.
2. The expert thesis — why the panel is bullish (traceable)
There is no expert coverage of BXP in the Synthos knowledge base. total_claims = 0; there are zero net-bullish and zero cautionary voices on file. None of the tracked high-skill investors we distill (the metabolic/AI/compounder-focused panel) have said anything traceable about an office REIT.
Accordingly, this note carries no expert-conviction weight and cites no claim_id values — because none exist. The verdict below is entirely fundamentals- and quant-driven, built from the FMP financials, analyst estimates, management's own SEC-filed guidance (§9), and our scoring framework. Where the Street has an opinion, we show it as context (24 Buy / 17 Hold / 1 Sell, consensus target $65.50), not as conviction. Absence of coverage is itself information: BXP is not a name the Synthos expert panel is leaning into.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 7 · Elevated | Cheap on FFO (~9.9×) and beta ~1.06, but 8.2× net-debt/EBITDA, a −48% max drawdown from peak, and office cyclicality/secular demand risk dominate. Leverage is the story. |
| Growth Quality | 3 · Weak | Revenue ~+1%/yr (FY24→FY25 +2.2%), FFO/share flat-to-down ($6.85 FY25 → $6.97 mid FY26E), ROE ~6%, ROIC ~5%. A durable income REIT, not a grower. |
| Exponential Potential | 2 · Very Low | Mature, decelerating, single-asset-class office landlord at $11B cap with no TAM-expansion optionality. The opposite of an accelerating multibagger. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities. For a REIT the honest valuation lever is FFO/share × a price/FFO multiple, plus the ~4% dividend collected along the way.
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | Office flight-to-quality accelerates; the ~1.6M sq ft signed-not-commenced backlog commences on schedule; asset sales de-lever toward ~7× and rates ease. FY27E FFO ~$7.30; multiple re-rates to ~12×. | ~$88 (+27%) |
| Base (our anchor) | Guidance roughly holds — FY26 FFO ~$6.97 (mgmt mid), essentially flat FY27; a leveraged, low-growth office REIT earns ~10× FFO. Add the ~4% dividend. | ~$70 (~+1% price, ~+5% total) |
| Bear | Office demand weakens again, SF/DC vacancy rises, refinancing at higher rates compresses FFO to ~$6.20, and the multiple de-rates to ~7.5× as leverage bites. | ~$48 (−31%) |
Synthos fair value = the base case, ~$70 (roughly flat on price, ~+5% total return with the dividend), with the full $48–$88 span as the honest range. This anchor sits above the Street's $65.50 consensus because we credit the covered dividend and the de-levering asset-sale plan; our bear is meaningfully below the Street's $61 low because we take the leverage-plus-office-secular tail seriously. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers-from-here). BXP is neither — it is a mature, cyclical income REIT:
- Forward growth: revenue CAGR FY25→FY30E is ~1.4% ($3.48B → ~$3.74B avg est); FFO/share is essentially flat (~$6.85 FY25 → ~$6.97 FY26E mid). This is a coupon, not a growth curve.
- Acceleration (2nd derivative): flat-to-negative. Revenue grew +2.2% FY25 vs +4.1% FY24; FFO/share is guided roughly flat-to-slightly-down FY26 vs FY25. Nothing is inflecting upward.
- Room to run: none in the Synthos sense. Office is a mature, arguably shrinking addressable market (secular hybrid-work headwind), and BXP is already the category leader. There is no TAM-expansion optionality — the upside case is a cyclical recovery + de-rating reversal, not a new S-curve.
- Reinvestment runway: development pipeline exists (six projects), but the current capital priority is de-levering via asset sales, i.e. shrinking, not compounding.
Exponential Potential: Very Low (2/10). Own BXP, if at all, for the ~4% yield and a cyclical office-recovery bet — never for exponential upside. This honest framing is why it cannot sit in a growth or "next-exponential" sleeve.
5. Financials (real numbers — FMP annual/quarterly)
Note: for a REIT, GAAP EPS and P/E are distorted by heavy depreciation; FFO (funds from operations) is the correct earnings proxy and is used throughout.
- Revenue: FY25 $3.48B, +2.2% (FY24 $3.41B, +4.1% on FY23 $3.27B). Low-single-digit, decelerating top line.
- FFO/share (management-reported): Q1'25 $1.64 → Q2 $1.71 → Q3 $1.74 → Q4 $1.76 → Q1'26 $1.59 ≈ ~$6.85 FY25; FY26 guided $6.90–$7.04 (mid $6.97). Flat.
- GAAP earnings (noisy): FY25 net income $276.8M, EPS $1.75 — but individual quarters swing on property gains/impairments (e.g. Q3'25 −$0.77, Q4'25 +$1.57). This is why P/E (35× trailing) is the wrong lens.
- Margins: gross ~60%, EBITDA margin ~54% TTM — healthy at the property level; the drag is below the line (interest).
- Cash flow: operating CF $1.25B FY25, capex ~−$0.56B, FCF ~$0.69B. Dividends paid $643M — covered by FCF and ~40% of FFO, the single most reassuring number here.
- Balance sheet (the concern): total debt $17.4B, net debt $15.9B, net-debt/EBITDA 8.2×, debt/equity ~3.1×, interest coverage ~1.95×. Cash $1.48B. Asset sales (~$1.2B proceeds to date) are being used to chip at this. Leverage is elevated but not acutely distressed — interest is covered ~2×.
6. Valuation — priced in or room?
On the right REIT metric, BXP is statistically cheap: ~9.9× FY26E FFO ($6.97 mid) and EV/EBITDA ~14×, with a ~4.0% dividend yield covered ~2.5× by FFO. Price/book is ~2.1× and the stock trades at ~$69 vs a ~$79 52-week high. The bear counter is that cheap is deserved: 8.2× net-debt/EBITDA, ~1% growth, and office secular risk justify a low multiple, and a rate-driven refinancing squeeze could push FFO and the multiple down together (the bear case). Street targets (context): consensus $65.50, high $72, low $61 — the Street essentially sees BXP as fairly-to-fully valued here, and our ~$70 base is modestly more constructive on the strength of the covered dividend and the de-levering plan. Not a value trap, but not a screaming bargain either — a fairly-priced, high-yield office REIT.
7. Technicals (from the FMP tech block)
- Trend: recovering/up. $69.32 sits above the 50-DMA ($61.75) and 200-DMA ($64.52), a constructive posture. MACD +1.77 (positive).
- Location: −12.2% off the 52-week high ($78.93), +35.9% off the 52-week low ($51.02). Notably, the max drawdown from the multi-year peak is −47.7% — a reminder of how hard office REITs were hit.
- Momentum: RSI(14) ~62 — firm but not overbought (<70).
- Relative strength (the tell): BXP +1.8% 12-mo vs SPY +20.6% and QQQ +30.3% — massive underperformance over a year, though it has outperformed recently (+35.9% 3-mo vs SPY +13.7%) off the lows on rate-cut hopes.
- Read: technicals show a cyclical bounce off a deep base, not a leadership uptrend. The 3-month rip is rate-sensitivity, not fundamental re-acceleration. A rate reversal would hit it hard; the setup argues for patience, not chasing.
8. Moat & competitive position
BXP's moat is irreplaceable trophy assets in supply-constrained gateway CBDs — you cannot easily build another Prudential Center or a new tower in Midtown, and the "flight to quality" within office genuinely favors the best-in-class landlord (Q1'26 CBD portfolio 93.4% leased vs 87.4% total occupancy). That is a real, if narrow, advantage. But it is a moat around a structurally challenged, single asset class: hybrid work has permanently lowered office demand, and BXP has no diversification into the REIT sectors that are growing (industrial, data centers, residential). The competitive frame is other high-quality office/coastal REITs (Alexandria) and the broader "avoid office entirely" allocation decision.
Peer set (market cap, from FMP — note these are mixed REITs, not pure office comps): Alexandria Real Estate (ARE) $9.2B (closest — life-science office), Camden Property Trust (CPT, apartments) $11.8B, UDR (apartments) $13.4B, American Homes 4 Rent (AMH) $12.2B, Equity LifeStyle (ELS) $12.8B, Host Hotels (HST) $16.0B, Rexford Industrial (REXR) $7.9B, Omega Healthcare (OHI) $14.7B, Lamar (LAMR) $16.0B, AGNC (mortgage) $12.6B. BXP is the office name in a peer list dominated by faster-growing, less-cyclical property types — which is itself a tell about where capital would rather be.
9. Management, capital allocation & guidance
- Capital allocation: the current playbook is de-lever and high-grade — ~$1.2B of asset sales to date recycled into balance-sheet flexibility and the development pipeline, while defending a covered dividend (~40% of FFO). Appropriate for the leverage level; the buyback is not a priority.
- Insider activity: the recent Form 4 flow is routine — director phantom-stock awards dated 2026-06-30 (non-cash comp), plus one officer sale (CFO Michael LaBelle, ~18,080 shares at ~$66.05 on 2026-06-09). No alarming discretionary-selling cluster in the sampled window; nothing to read into.
- Management's own guidance (half-weighted — their self-interested words): the SEC 8-K Q1'26 earnings release (filed 2026-04-28) is a real earnings release with explicit forward guidance. Management guided Q2'26 EPS $0.44–$0.46 and FFO $1.69–$1.71/share, and raised full-year 2026 EPS to $2.15–$2.29 and FFO to $6.90–$7.04/share (FFO midpoint up $0.01, EPS midpoint up $0.04, "primarily due to gains on sales… and better-than-projected portfolio performance"). They also flagged total portfolio occupancy +70 bps QoQ to 87.4%, a 350-bps leased-vs-occupied spread (~1.6M sq ft of signed leases yet to commence, ~90% expected to commence in 2026), and ~$1.2B of asset-sale proceeds to date. Treated as management's own book (half-weight): the guidance is credible but unexciting — flat FFO with a de-levering narrative, consistent with the fundamentals above.
10. Catalysts & what to watch
- Next earnings: 2026-07-28 (Q2'26; Street EPS $0.43; management FFO guide $1.69–$1.71). Key lines: occupancy trend, the signed-not-commenced lease backlog commencing, and any FFO-guide revision.
- Interest rates: the dominant swing factor — BXP is highly rate-sensitive (refinancing 8.2× leverage). Rate cuts help the multiple and FFO; higher-for-longer hurts both.
- Asset-sale de-levering: progress toward lower net-debt/EBITDA is the balance-sheet tell.
- San Francisco / DC office demand: the most challenged markets; recovery there is the bull's proof point.
- Dividend: watch FFO coverage — a cut would be a thesis-breaker; today it is comfortably covered.
Thesis tripwires (what would change the call): two quarters of occupancy decline; FFO guide cut below ~$6.50; interest coverage slipping toward ~1.5×; or a dividend reduction. Upgrade triggers: sustained occupancy gains + de-levering below ~7× + FFO re-accelerating.
11. Key risks
- Office secular demand (structural): hybrid/remote work has permanently reduced office need; a single-asset-class landlord is fully exposed. No expert in the KB offsets this view — the risk stands on the fundamentals.
- Leverage / refinancing (the dominant quant flag): 8.2× net-debt/EBITDA and ~1.95× interest coverage into a higher-for-longer rate regime; refinancing at higher rates compresses FFO (bear case).
- Rate sensitivity: the recent +36% 3-month move was largely rate-driven; a reversal would unwind it.
- Concentration: ~37% Boston + ~30% New York rental revenue; San Francisco (~15%) is the most challenged market.
- Valuation looks cheap for a reason: the low multiple is the market pricing leverage + secular risk, not a mispricing to arbitrage.
- No conviction cushion: with zero KB coverage, there is no independent expert signal to lean on if fundamentals wobble.
12. Verdict, position sizing & monitoring
Watch. BXP is a cheap-looking, high-quality office REIT — best-in-class trophy assets, a covered ~4% dividend, ~9.9× forward FFO, and a credible de-levering plan. But the top line has flatlined (~1%/yr), FFO is flat, the balance sheet carries 8.2× net-debt/EBITDA into an uncertain-rate world, and the asset class faces a real secular headwind. With no expert conviction in the Synthos KB, nothing pushes this from a fairly-valued income name to a buy. It is not a sell — the dividend is covered and the assets are real — but it does not clear the bar for fresh capital.
- Sizing: if held at all, income/tactical, ≤2% of a portfolio for the yield and a cyclical office-recovery bet — never a core position.
- Monitoring: re-underwrite on the tripwires in §10; formal re-score each earnings print. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $69.32.
- Single biggest risk: office secular demand compounded by 8.2× leverage in a higher-for-longer rate world.
Provenance & disclosures
- Traceability: 0 KB claims — no expert coverage of BXP in the Synthos knowledge base. This note is fundamentals- and quant-driven; no
claim_ids are cited because none exist. Fabricated conviction is structurally impossible (claim-ID reconciliation). - Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · management guidance from the SEC 8-K filed 2026-04-28. Forward figures are analyst consensus / management guidance (FMP + SEC), labeled as estimates.
- REIT note: FFO (not GAAP EPS) is used as the earnings proxy throughout; P/E is shown only to flag that it is misleading here.
- Management caveat: BXP management guidance is management's own book, half-weighted by design.
- Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
- Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").